According to the latest report by IMARC Group, titled “Global Biopharmaceutical Manufacturing Market Report 2020-2025”, the market is currently witnessing strong growth. The global biopharmaceutical manufacturing market to exhibit moderate growth during the next five years. The manufacturing of biopharmaceuticals (biopharma) is characterized by a highly complex research and development (R&D) setting, which includes using numerous technologies harnessed by new scientific advancements. The biopharmaceutical manufacturing process supports a wide range of specialized procedures, including packaging, blending, testing, inspection, sampling, sorting, chemical equipment operating, etc. The different methods deployed for the production of biopharmaceuticals involve continuous and follow-on manufacturing systems.
Get a sample copy of this Report: https://www.imarcgroup.com/global-biopharmaceutical-manufacturing-market/requestsample
As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the purchase behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.
The advent of the industrial revolution 4.0 is encouraging the digitalization of various biopharma manufacturing processes that involve machines to collect, process, and produce data and then communicate it with other devices through the Industrial Internet of Things (IIoT). This is primarily driving the biopharmaceutical manufacturing market across the globe. In line with this, these next-generation technologies are assisting industry players in enhancing process understanding by providing advanced modeling techniques and analytics, which is further catalyzing the market growth. Additionally, the increasing adoption of advanced manufacturing technologies and methods in developing economies, such as India and China, is also augmenting the global market. Furthermore, the expanding biopharmaceutical industry is leading to the emerging trend of outsourcing, owing to the high costs and lack of expertise in in-house manufacturing. Consequently, several contract manufacturing organizations (CMOs) are investing heavily to expand their existing infrastructures. This, in turn, is anticipated to stimulate the biopharmaceutical manufacturing market over the forecasted period.
View Full Report with TOC & List of Figure: https://www.imarcgroup.com/global-biopharmaceutical-manufacturing-market
Competitive Landscape with Key players:
The report has also analysed the competitive landscape of the market with some of the key players being.
- Hoffmann-La Roche Ltd
- Amgen Inc.
- Novo Nordisk A/S
- AbbVie Inc.
- Groupe Sanofi
- Johnson & Johnson Services, Inc.
- Pfizer Inc.
- Merck & Co., Inc.
- Eli Lilly and Company
- Biogen Inc
Biopharmaceutical Manufacturing Market Segmentation:
Our report has categorized the market based on region, cell culture and class.
Breakup by Cell Culture:
- Mammalian
- Microbial
Breakup by Class:
- Monoclonal Antibodies
- Recombinant Proteins
- Interferon
- Granulocyte Colony-Stimulating Factor (G-CSF)
- Erythropoietin
- Recombinant Human Insulin
- Vaccines
- Human Growth Hormones (HGH)
Regional Insights:
- North America (United States, Canada)
- Europe (Germany, France, United Kingdom, Italy, Spain, Others)
- Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)
Key highlights of the report:
- Market Performance (2015-2020)
- Market Outlook (2021-2026)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
We are updating our reports, If you want latest primary and secondary data (2021-2026) with Cost Module, Business Strategy, Competitive landscape, etc. Click request free sample report, the report will be delivered to you in PDF format via email within 24 to 48 hours after the payment confirmation.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US:
IMARC Group
30 N Gould St Ste R
Sheridan, WY 82801 USA - Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
No comments:
Post a Comment